###begin article-title 0
Beta-Catenin Signaling Plays a Disparate Role in Different Phases of Fracture Repair: Implications for Therapy to Improve Bone Healing
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 188 195 <span type="species:ncbi:9606">patient</span>
Delayed fracture healing causes substantial disability and usually requires additional surgical treatments. Pharmacologic management to improve fracture repair would substantially improve patient outcome. The signaling pathways regulating bone healing are beginning to be unraveled, and they provide clues into pharmacologic management. The beta-catenin signaling pathway, which activates T cell factor (TCF)-dependent transcription, has emerged as a key regulator in embryonic skeletogenesis, positively regulating osteoblasts. However, its role in bone repair is unknown. The goal of this study was to explore the role of beta-catenin signaling in bone repair.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 208 213 <span type="species:ncbi:10090">mouse</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
Western blot analysis showed significant up-regulation of beta-catenin during the bone healing process. Using a beta-Gal activity assay to observe activation during healing of tibia fractures in a transgenic mouse model expressing a TCF reporter, we found that beta-catenin-mediated, TCF-dependent transcription was activated in both bone and cartilage formation during fracture repair. Using reverse transcription-PCR, we observed that several WNT ligands were expressed during fracture repair. Treatment with DKK1 (an antagonist of WNT/beta-catenin pathway) inhibited beta-catenin signaling and the healing process, suggesting that WNT ligands regulate beta-catenin. Healing was significantly repressed in mice conditionally expressing either null or stabilized beta-catenin alleles induced by an adenovirus expressing Cre recombinase. Fracture repair was also inhibited in mice expressing osteoblast-specific beta-catenin null alleles. In stark contrast, there was dramatically enhanced bone healing in mice expressing an activated form of beta-catenin, whose expression was restricted to osteoblasts. Treating mice with lithium activated beta-catenin in the healing fracture, but healing was enhanced only when treatment was started subsequent to the fracture.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
These results demonstrate that beta-catenin functions differently at different stages of fracture repair. In early stages, precise regulation of beta-catenin is required for pluripotent mesenchymal cells to differentiate to either osteoblasts or chondrocytes. Once these undifferentiated cells have become committed to the osteoblast lineage, beta-catenin positively regulates osteoblasts. This is a different function for beta-catenin than has previously been reported during development. Activation of beta-catenin by lithium treatment has potential to improve fracture healing, but only when utilized in later phases of repair, after mesenchymal cells have become committed to the osteoblast lineage.
###end p 6
###begin p 7
###xml 14 18 <span type="species:ncbi:10090">mice</span>
In a study in mice Benjamin Alman and colleagues show that beta-catenin functions differently in different stages of fracture repair; moreover, activation of beta-catenin by lithium improves fracture healing when used in later phases of repair.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 5 11 <span type="species:ncbi:9606">people</span>
Most people break at least one bone during their life. If the damaged bone is immobilized with a plaster cast or with metal plates and pins, most fractures heal naturally and quickly. Soon after a bone is damaged, cells called pluripotent mesenchymal cells collect at the injury site. Here, they multiply and change (differentiate) into osteoblasts (cells that make bone) and chondrocytes (cells that make cartilage, the dense connective tissue that covers joints). Osteoblasts and chondrocytes mend the fracture by making new bone, a process called ossification. Bone healing involves two types of ossification. In intramembranous ossification, mesenchymal cells and osteoblast progenitor cells make bone directly, forming a hard "callus" within the fracture. In endochondral ossification, mesenchymal cells differentiate into chondrocytes and make cartilage at the fracture site, which osteoblasts turn into bone. Finally, the bone made by both types of ossification is remodeled so that it closely resembles the damaged bone's original shape and strength.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
Unfortunately, fractures do not always heal efficiently. If healing is delayed, additional surgery may be needed to repair the break. But surgery can be risky, so drug-based ways of encouraging bone repair would be very useful. To develop such treatments, researchers need to understand what controls the differentiation and activity of osteoblasts and chondrocytes during normal healing. In this study, the researchers have investigated the role of the beta-catenin signaling pathway in bone repair. This pathway regulates bone formation during embryonic development, a process that closely resembles bone healing. beta-catenin is usually degraded rapidly in cells. However, if a member of a particular family of proteins known as the WNT family binds to a WNT receptor on the surface of a cell, beta-catenin moves into the cell's nucleus where it interacts with a protein called T cell factor (TCF). This interaction activates the transcription (the copying of DNA into messenger RNA, which is used to make proteins) of numerous genes and alters the behavior of the cell.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
The researchers first measured beta-catenin levels in mouse and human bones. In both species, much more beta-catenin was made in bones undergoing repair than in intact bones. Then they studied TCF reporter mice-animals in which TCF controls the expression of a marker gene. beta-catenin-mediated TCF-dependent transcription, they report, was activated during both bone and cartilage formation after a fracture in these mice. Next, the researchers made mice that could be induced to express an inactive form of beta-catenin or a stabilized (permanently active) form of beta-catenin in all the cells in a bone fracture. Expression of inactive beta-catenin slowed the rate of healing but, unexpectedly, so did expression of stabilized beta-catenin. Osteoblast-specific expression of inactive beta-catenin also delayed bone healing, whereas osteoblast-specific expression of stabilized beta-catenin enhanced the process. Finally, treatment of wild-type mice with lithium (which prevents the degradation of beta-catenin) enhanced bone healing if given after a fracture, but interfered with it if given before.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 660 666 <span type="species:ncbi:9606">people</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
These findings indicate that beta-catenin signaling (which, the researchers show, is mainly activated by WNT signaling) has different effects at different stages of bone repair. Early in the process, it controls the ratio of osteoblasts and chondrocytes made from the pluripotent mesenchymal cells. Consequently, too much or too little beta-catenin interferes with bone healing at this stage. Later on, beta-catenin promotes the differentiation of osteoblasts and enhances their ability to make bone, and so too little beta-catenin at this stage prevents healing, whereas increased beta-catenin levels stimulate healing. These findings need to be confirmed in people before testing agents that affect beta-catenin signaling for their effects on human bone healing. Nevertheless, the researchers' final discovery that lithium improves bone healing if given at the right time is particularly encouraging; lithium is widely used to treat one form of depression so could be readily tested in clinical trials.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
MedlinePlus encyclopedia contains pages on  and on  (in English and Spanish)
###end p 19
###begin p 20
Wikipedia has pages on  and on  (note: Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)
###end p 20
###begin p 21
The UK National Health Service Direct encyclopedia provides pages on 
###end p 21
###begin p 22
Animations of  are available from the Ministry of Advanced Education, Training and Technology, Province of British Columbia, Canada
###end p 22
###begin p 23
The American Academy of Orthopedic Surgeons has an 
###end p 23
###begin p 24
###xml 22 30 <span type="species:ncbi:9606">Children</span>
The Hospital for Sick Children in Toronto (where the authors of this study are affiliated) has a Web site called , which contains a page on , including diagrams of bone development
###end p 24
###begin title 25
Introduction
###end title 25
###begin p 26
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b001">1</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b002">2</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b003">3</xref>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b004">4</xref>
###xml 1124 1125 1124 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b006">6</xref>
###xml 1279 1287 <span type="species:ncbi:9606">patients</span>
###xml 1714 1721 <span type="species:ncbi:9606">patient</span>
Fracture healing is a complex regenerative process initiated in response to injury, which in the optimal case results in restoration of skeletal function. In the initial phase of fracture repair, undifferentiated mesenchymal cells aggregate at the site of injury, proliferate, and differentiate, presumably in response to growth factors produced by the injured tissues [1]. This process involves both intramembranous and endochondral ossification. Intramembranous ossification involves the formation of bone directly from committed osteoprogenitor cells and undifferentiated mesenchymal cells that reside in the periosteum, resulting in hard callus formation [2,3]. During endochondral ossification, mesenchymal cells differentiate into chondrocytes, producing cartilaginous matrix, which then undergoes calcification and eventually is replaced by bone. The formation of primary bone is followed by extensive remodeling until the damaged skeletal element regains original shape and size. These processes are reminiscent of embryonic bone development, suggesting that fracture repair recapitulates normal bone development [4-6]. When fracture healing is impaired, osteoblastic differentiation is inhibited, and undifferentiated mesenchymal tissue remains at the fracture site. In patients, this outcome results in delayed union, or nonunion, usually requiring additional surgery for successful fracture healing. In certain surgeries, such as spinal fusion surgery or total joint replacement, a lack of bone ingrowths results in a failed outcome and the need for additional surgery. A pharmacologic adjunct to improve bone healing has the potential to avoid the need for additional surgery in these cases, improving patient outcomes.
###end p 26
###begin p 27
###xml 85 86 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b007">7</xref>
###xml 87 88 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b008">8</xref>
###xml 477 478 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b009">9</xref>
###xml 867 869 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b010">10</xref>
###xml 870 872 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b012">12</xref>
###xml 1133 1135 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b013">13</xref>
###xml 1560 1562 1542 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b014">14</xref>
###xml 1563 1565 1545 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b015">15</xref>
###xml 1674 1676 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b016">16</xref>
###xml 1677 1679 1656 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b018">18</xref>
beta-catenin signaling has emerged as a key regulator of embryonic bone development [7,8]. Secreted WNT ligands and antagonists of WNT signaling bind to the transmembrane receptors including low-density lipoprotein jureceptor-related protein 5/6 (LRP5/6) and frizzled (FZ) to regulate the WNT pathway. WNT signaling activation produces a cytoplasmic signaling cascade leading to the transcriptional regulation of gene expression, cytoskeletal reorganization, and calcium flux [9]. Signaling through the canonical WNT pathway is initiated by the binding of appropriate WNT ligands to the FZs and LRP5/6 co-receptor. In the absence of appropriate WNT ligands, beta-catenin is targeted for phosphorylation, ubiquitination and proteosomal degradation by a multi-protein complex comprising glycogen synthase kinase 3 beta (GSK3beta), adenomatous polyposis coli, and axin [10-12]. In the presence of an appropriate WNT ligand, this multi-protein complex is dissociated by dishevelled (DVL), an intracellular mediator that plays a central role in transducing the signal from the receptor complex, leading to the activation of beta-catenin [13]. Hence, beta-catenin cannot be targeted for degradation and translocates to the nucleus, where in concert with members of the T cell factor/lymphoid enhancer factor (TCF/LEF) family, activates the transcription of a wide range of genes. During embryonic skeletogenesis, inhibition of beta-catenin signaling can block osteoblast differentiation and shift pluripotent mesenchymal cells to develop a chondroblastic phenotype [14,15]. beta-catenin signaling also can regulate bone mass, and its activation results in increased bone density [16-18].
###end p 27
###begin p 28
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b019">19</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b020">20</xref>
###xml 487 527 487 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNT1-induced secreted protein 1 (WISP1),</italic>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b021">21</xref>
###xml 798 800 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b022">22</xref>
###xml 938 940 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b023">23</xref>
###xml 1251 1259 <span type="species:ncbi:9606">patients</span>
Although the histology and general mechanism of fracture repair are clear and well established, much remains to be understood about the process of bone healing, particularly at the molecular signaling level. Based on a microarray analysis, it was found that WNT pathway members are expressed during fracture repair [19]. DVL is expressed during fracture repair and when blocked using small interfering RNAs (siRNAs), inhibits both proliferation and differentiation of chondrocytes [20]. WNT1-induced secreted protein 1 (WISP1), a WNT target gene, is also expressed during fracture healing, and overexpression of this gene increases proliferation but decreases the differentiation in a chondrocytic cell line [21]. We previously reported that beta-catenin regulates wound size during dermal repair [22], and that oral lithium treatment could be used to activate beta-catenin signaling and to increase the size of healing cutaneous wounds [23]. Based on these findings, it is likely that beta-catenin plays a role in fracture repair. In this study, we aimed at investigating how beta-catenin signaling functions during fracture healing, and to test for the effect of lithium treatment. Since lithium is a pharmacologic agent already approved for use in patients, this approach could be developed into a novel therapy to improve bone healing.
###end p 28
###begin title 29
Methods
###end title 29
###begin title 30
Ad-DKK1 and Ad-Cre
###end title 30
###begin p 31
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DKK1</italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b024">24</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b022">22</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b022">22</xref>
###xml 140 146 <span type="species:ncbi:10090">murine</span>
###xml 312 315 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
Dickkopf 1 (DKK1) is a secreted protein that binds to LRP5/6 and Kremen proteins, blocking canonical WNT signaling. An adenovirus harboring murine DKK1 cDNA with a C-terminal His6 and Flag epitope tags (Ad-DKK1) was generated and utilized as previously described [24]. Cre recombinase expression was driven by a CMV promoter in an adenovirus construct (Ad-Cre) generated and utilized as previously described [22]. The same adenovirus expressing GFP was utilized as a control. Ad-Cre's ability to cause recombination was assessed using reporter mice as we previously described [22]; it resulted in recombination in roughly 75% of cells.
###end p 31
###begin title 32
###xml 11 15 <span type="species:ncbi:10090">Mice</span>
Transgenic Mice
###end title 32
###begin p 33
###xml 5 11 5 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 18 20 18 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b025">25</xref>
###xml 172 180 169 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 167 180 164 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 187 189 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b026">26</xref>
###xml 374 376 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b022">22</xref>
###xml 388 392 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 414 419 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 555 559 542 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 540 560 531 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup>,</italic>
###xml 586 599 573 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Cre</italic>
###xml 606 608 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b027">27</xref>
###xml 620 626 603 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 615 626 598 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 724 728 700 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 709 729 689 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup>,</italic>
###xml 755 768 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Cre</italic>
###xml 784 792 756 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 779 792 751 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 799 812 771 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Cre</italic>
###xml 1042 1044 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b025">25</xref>
###xml 1045 1047 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b027">27</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">Mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 1012 1017 <span type="species:ncbi:10090">mouse</span>
Catnbtm2Kem mice [25] possess loxP sites located in introns 1 and 6 of the gene encoding beta-catenin, resulting in a null allele when treated with a Cre recombinase. Catnblox(ex3) mice [26] contain loxP sequences flanking exon 3, and when subjected to Cre recombinase, results in the expression of a fully functional but stabilized beta-catenin protein. TCF reporter mice [22] contain a LacZ gene downstream of a c-fos minimal promoter and three consensus TCF-binding motifs. Mice expressing osteoblast-specific beta-catenin null alleles, alpha1(I)-Catnbnull, were generated by mating alpha1(I)-Cre mice [27] with Catnbtm2Kem animals, and mice expressing osteoblast-specific beta-catenin stabilized alleles, alpha1(I)-Catnbstab, were generated by mating alpha1(I)-Cre mice with Catnblox(ex3) mice. alpha1(I)-Cre mice express the Cre recombinase at high levels in cells committed to the osteoblast lineage. Activation of the conditional alleles was confirmed by Western blot analysis and by using a Cre-reporter mouse as previously reported [25-27].
###end p 33
###begin title 34
Generation of Fractures
###end title 34
###begin p 35
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b028">28</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b028">28</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b029">29</xref>
###xml 859 860 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 1320 1322 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b030">30</xref>
###xml 1323 1325 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b031">31</xref>
###xml 103 111 <span type="species:ncbi:9606">Children</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 869 874 <span type="species:ncbi:10090">mouse</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1245 1251 <span type="species:ncbi:9606">humans</span>
###xml 1314 1318 <span type="species:ncbi:10090">mice</span>
###xml 1559 1563 <span type="species:ncbi:10090">mice</span>
All animal procedures were reviewed and approved by the animal care committee of the Hospital for Sick Children in Toronto. Male mice aged 12 wk were utilized for this study. A stabilized fracture was generated as previously reported with minor modifications [28]. Briefly, a small incision was made on the dorsolateral side of the thigh and was extended over the knee region. A longitudinal incision was made in the patellar tendon, and a 0.5 mm hole was drilled above the tibia tuberosity. Intramedullary fixation was made by placing an Anticorro insect pin (Fine Science Tools, ) in the marrow space. A fracture was then made by cutting the shaft of tibia. Previous data show that a fracture generated in this manner heals through both endochondral and intramembranous ossification [28,29]. For virus treatment, Ad-DKK1, Ad-Cre, or Ad-GFP at a dosage of 109 pfu per mouse was mixed with Matrigel (BD Biosciences, ) and injected into the fracture site using a microsyringe. For mice treated with lithium, sterile 0.6 M LiCl (or 0.6 M NaCl as a control) was added to the drinking water leading to a final concentration of 0.02 M. This oral dosage (approximately200 mg/kg per day, a dose giving plasma levels comparable with level used to treat humans with bipolar illness), previously reported to be effective in mice [30,31], was administered either 2 wk prior to, or 4 d after fracture. The animals were allowed free, unrestricted weight bearing in cages after recovery from anesthesia. At different time points (3, 4, 7, 14, and 21 d) after the fracture, mice were sacrificed and fracture callus was harvested for further analysis. At least five animals at each time point for each experimental condition were studied.
###end p 35
###begin title 36
Evaluation of Fracture Healing
###end title 36
###begin p 37
###xml 664 665 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1123 1127 1120 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 1217 1219 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b032">32</xref>
Animals were examined using Faxitron MX20 X-ray system (Faxitron X-ray Corporation, ) for radiographic appearance, and for quantitative analysis of the bone mineral density at the fracture site using the Lunar PIXI Small Animal Bone Densitometer (). For histological analysis, the tissue at the fracture site was harvested, fixed in 4% paraformaldehyde, decalcified in 20% EDTA (pH 7.4), and embedded in paraffin. Sections 10 mum thick were prepared and stained with hematoxylin-eosin (HE) and safranin O (SO). For histomorphometric measurements, an average of ten tissue sections was used to determine callus parameters. An analysis image window, measuring 1.6 mm2, was established for evaluation of cartilage or bone volume as a percentage of total callus tissue volume, trabecular thickness (mum), trabecular number (per mm), and trabecular separation (mum). The radiographs, bone mineral density, and histological parameters of the cartilage and bone were evaluated in a blinded manner by an independent investigator. At least four animals were analyzed for each group for histological and radiographic parameters. For LacZ staining, samples were fixed in 4% paraformaldehyde and stained as previously described [32]. Samples were then decalcified in 20% EDTA, and embedded in paraffin. Sections were counterstained with Neutral Red.
###end p 37
###begin title 38
Reverse Transcription PCR and Western Blot
###end title 38
###begin p 39
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b032">32</xref>
###xml 443 451 443 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-st001">Table S1</xref>
###xml 929 937 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-st002">Table S2</xref>
###xml 649 660 <span type="species:ncbi:3704">horseradish</span>
Total RNA and protein were isolated from the fracture site, which encompassed the entire callus and less than 2 mm of adjacent bone. This area corresponds to approximately those bounded by the lines indicating the proximal and distal aspect of the fracture callous in the low-magnification histological images of the fractures. Quantitative reverse transcription PCT (RT-PCR) was performed as previously described [32], with primers listed in Table S1. Expression was compared to beta-2 macroglobin as a "housekeeping" control. All experiments were performed in triplicate. Western blot analysis was performed using select antibodies detected using horseradish peroxidase-conjugated secondary antibody and the ECL chemiluminescence detection system (Amersham, ). Relative expression levels were quantified by densitometry using AlphaEaseFC software (Alpha Innotech, ). Specific antibodies utilized in this work are listed in the Table S2.
###end p 39
###begin title 40
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Fracture Sample
###end title 40
###begin p 41
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
Samples from healing fractures from three patients undergoing corrective surgery for a fracture malunion, two performed 3 wk following the initial fracture and one performed 3 mo following the initial fracture, were cryopreserved as soon as possible after surgery. The patients gave written informed consent to remove fracture samples. These samples were analyzed by Western blot in an identical manner to the mouse studies.
###end p 41
###begin title 42
Statistical Analyses
###end title 42
###begin p 43
###xml 106 107 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 217 218 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data were expressed as mean +/- standard deviation. Statistical differences were calculated using Student t test. A minimum of four animals were analyzed for each group for histological and radiographic parameters. A p-value below 0.05 was considered statistically significant.
###end p 43
###begin title 44
Results
###end title 44
###begin title 45
beta-Catenin Signaling Is Activated during Fracture Healing
###end title 45
###begin p 46
###xml 395 397 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b028">28</xref>
###xml 398 400 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b029">29</xref>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 255 261 <span type="species:ncbi:10090">murine</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
To determine the protein level of beta-catenin during fracture healing, we performed Western blot analysis on protein from the healing callus at different time periods in TCF reporter mice with stabilized tibia fractures. Previous studies show that these murine fractures heal through intramembranous and endochondral ossification by a mechanism similar to that in normal human fracture repair [28,29].
###end p 46
###begin p 47
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 212 220 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 163 168 <span type="species:ncbi:9606">human</span>
As shown in Figure 1A, beta-catenin protein level is low in intact bone tissue, but is highly expressed during the entire period of fracture repair. Data from the human fracture samples showed a similar pattern (Figure 1B), with high levels of beta-catenin, more than twice that of intact bone, in the fracture callus 3 wk after the initial fracture, but low levels 3 mo following the initial injury.
###end p 47
###begin title 48
beta-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing
###end title 48
###begin p 49
###xml 109 113 <span type="species:ncbi:10090">mice</span>
(A) Western blot analysis at different time points shows that beta-catenin is elevated throughout healing in mice.
###end p 49
###begin p 50
###xml 42 47 <span type="species:ncbi:9606">human</span>
(B) beta-catenin is also increased during human fracture healing.
###end p 50
###begin p 51
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
(C-T) LacZ staining for TCF-dependent transcriptional activity in intact tibia (C-E); at 3 d following the tibia fracture (F-H); at 9 d following the fracture (I-K); at 2 wk following fracture (L-N); at 3 wk following fracture (O-Q); and at 5 wk following fracture (R-T). Images on the left (C, F, I, L, O, and R), at 25x, show the entire fracture callus (lines show the proximal and distal aspect of the fracture callus); in the center (D, G, J, M, P, and S) are 100x magnifications of areas shown in the boxes in the lower-magnification images; and on the right (E, H, K, N, Q, and T), the same images are magnified to 200x.
###end p 51
###begin p 52
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
TCF-dependent transcriptional activity was maintained at a very low level in osteoblasts near the growth plate in normal intact tibia, and there was no positive staining in cells surrounding the mature bone tissue. Three days following fracture, very weak LacZ (barely detectable) staining was detected in mesenchymal tissues at the fracture site. Nine days following fracture, positive staining was evident mainly in cells surrounding cartilage matrix and osteoblasts along the trabeculae and periosteum. Chondrocytes and prehypertrophic chondrocytes also stained at 2 wk after the fracture. Osteoblasts consistently displayed strong staining signals at 2 and 3 wk following fracture. At the 5 wk time point, LacZ staining occurred mainly in osteoblasts in the periosteum either next to, or farther away from, the fracture site.
###end p 52
###begin p 53
###xml 186 190 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 318 326 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 328 329 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">1</xref>
###xml 471 475 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 486 494 483 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 496 497 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">1</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Using TCF reporter mice, we observed in which cells beta-catenin mediated TCF-dependent transcription was activated during the fracture process. In the intact tibia, there was only weak LacZ staining signal in osteoblasts near the growth plate, and there was no positive staining in cells surrounding the mature bone (Figure 1C-1E). At 3 d after the fracture, undifferentiated fibroblast-like mesenchymal cells filled the fracture gap, and there was only small amount of LacZ staining (Figure 1F-1H).
###end p 53
###begin p 54
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">1</xref>
By 9 d following the fracture, most of the callus was composed of cartilage. Some cartilage cells exhibited a hypertrophic phenotype and woven bone was also present. Cells surrounding the cartilaginous matrix showed strong LacZ staining. Chondrocytes also displayed staining signal, and the staining intensity was greatly decreased in prehypertrophic chondrocytes, and no staining was found in hypertrophic chondrocytes. Osteoblasts along the trabeculae or periosteum displayed a strong staining intensity (Figure 1I-1K).
###end p 54
###begin p 55
###xml 423 431 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">1</xref>
The 2 wk post-fracture time point corresponds to the hard callus stage when hypertrophic cartilage is being actively replaced by woven bone. Hypertrophic chondrocytes did not exhibit staining. Osteoblasts either lining the periosteum or along the islands of woven bone within the provisional callus also showed strong staining signal. However, the intensity of staining became fainter as osteoblasts matured to osteocytes (Figure 1L-1N).
###end p 55
###begin p 56
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">1</xref>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 522 530 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">Figure 1</xref>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g001">1</xref>
The callus was composed primarily of bone 3 wk after the fracture, and cartilage was barely detected. LacZ staining was detected in osteoblasts but there was a very low level of staining in the fully differentiated osteocytes (Figure 1O-1Q). The 5 wk post-fracture time point corresponds to the bone remodeling phase, and the callus was composed of bone undergoing remodeling. At this time point, LacZ staining was mainly detected in osteoblasts residing in periosteum both adjacent to and farther from the fracture site (Figure 1R-1T).
###end p 56
###begin p 57
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
In addition, since background LacZ staining can occur in wild-type animals, we also performed this staining on wild-type mice, and we failed to detect positive LacZ staining signals during fracture healing.
###end p 57
###begin p 58
These observations suggest that beta-catenin-mediated, TCF-dependent transcription is activated in both bone and cartilage formation during fracture healing. In particular, during endochondral ossification, beta-catenin signaling is activated at the early stages of chondrogenesis, but not at later stages of chondrogenesis (i.e., hypertrophic chondrocytes). During osteogenesis, beta-catenin is activated in cells with an osteoblast phenotype, but is down-regulated when osteoblasts undergo maturation into osteocytes.
###end p 58
###begin title 59
Precise Regulation of beta-Catenin Signaling Is Required for Fracture Healing
###end title 59
###begin p 60
###xml 165 171 162 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 160 171 157 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 180 188 177 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 175 188 172 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 313 315 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b025">25</xref>
###xml 316 318 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b026">26</xref>
###xml 603 611 594 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">Figure 2</xref>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
To determine the role of beta-catenin during fracture healing, we utilized a loss-of-function and gain-of-function approach. The repair process was observed in Catnbtm2Kem or Catnblox(ex3) mice, which conditionally express null or stabilized beta-catenin alleles, respectively, when subjected to Cre recombinase [25,26]. Ad-Cre was injected into the fracture site to promote the recombination of the conditional alleles. Ad-GFP was used as a control. Western blot analysis on protein from the fracture callus showed that treatment with Ad-Cre resulted in striking regulation of beta-catenin expression (Figure 2A). To study the effect of the virus itself on fracture repair, we generated tibia fractures in wild-type mice and found no radiographic or histological difference in the healing phenotype after injection with either the Ad-Cre or the Ad-GFP control virus
###end p 60
###begin title 61
beta-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture Healing
###end title 61
###begin p 62
###xml 73 81 73 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 68 81 68 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 90 96 90 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 85 96 85 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 135 150 <span type="species:ncbi:10090">transgenic mice</span>
Ad-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.
###end p 62
###begin p 63
(A) Regulation of beta-catenin protein by Cre recombinase-mediated recombination of beta-catenin alleles was confirmed by Western blot analysis of the fracture callus, which was harvested at 3 wk after the fracture. The stabilized mutant beta-catenin protein is slightly smaller due to deletion of exon 3.
###end p 63
###begin p 64
###xml 53 59 53 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 48 59 48 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 90 98 90 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 85 98 85 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
(B-D) Radiographic analysis from Ad-Cre-treated Catnbtm2Kem mice (B), Ad-Cre-treated Catnblox(ex3) mice (C), and Ad-GFP-treated control mice (D). At 3 wk after fracture, a lack of healing was seen in the mice expressing the null and stabilized alleles. Arrows indicate fracture site.
###end p 64
###begin p 65
###xml 43 49 43 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 38 49 38 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 86 94 86 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 81 94 81 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 367 375 364 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 362 375 359 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
(E-J) HE staining from Ad-Cre-treated Catnbtm2Kem mice (E and H); Ad-Cre-treated Catnblox(ex3) mice (F and I), and Ad-GFP-treated control mice (G and J). The fracture sites consisted mainly of undifferentiated mesenchymal-like tissues in mice expressing either the null or stabilized beta-catenin alleles, and there was still less remaining cartilage present in Catnblox(ex3) mice at 3 wk after fracture. Histomorphometric analysis was conducted to analyze bone regeneration. Photomicrographs in the center row (E, F, and G) are magnified 25x; lines show the proximal and distal aspects of the healing fracture site. Images in the bottom row (H, I, and J) are 100x magnifications of areas shown in the boxes in the lower-magnification images.
###end p 65
###begin p 66
(K) Bone volume (BV) is expressed as a percentage of total callus tissue volume (TV).
###end p 66
###begin p 67
###xml 132 136 <span type="species:ncbi:10090">mice</span>
(L) Western blot of SOX9 at 1 wk and RUNX2 at 3 wk following fracture shows a decrease of both markers in the Cre-null and Cre-stab mice.
###end p 67
###begin p 68
(M) Relative expression of SOX9 and RUNX2 were quantified using densitometry;
###end p 68
###begin p 69
###xml 115 121 115 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 110 121 110 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">Figure 2</xref>
###xml 230 238 230 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 225 238 225 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 433 441 430 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">Figure 2</xref>
###xml 499 505 496 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 494 505 491 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 609 617 606 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 604 617 601 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 703 709 700 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 698 709 695 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 764 772 761 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">Figure 2</xref>
###xml 774 775 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">2</xref>
###xml 894 903 891 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">Figures 2</xref>
###xml 909 911 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg001">S1</xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 877 892 <span type="species:ncbi:10090">transgenic mice</span>
At 3 wk following fracture, radiographic examination showed no evidence of bone bridging the fracture site in Catnbtm2Kem mice treated with Ad-Cre, and there was little new bone formation (Figure 2B). To our surprise, in the Catnblox(ex3) mice, in which gene encoding beta-catenin was conditionally stabilized after treatment with Cre recombinase, radiographic analysis also did not show evidence of bone bridging the fracture site (Figure 2C). Upon histological examination, fracture sites in Catnbtm2Kem mice mainly consisted of undifferentiated mesenchymal-like tissues, with no osteoblasts detected. Catnblox(ex3) mice, however, showed a surprisingly similar histological appearance to that in Catnbtm2Kem mice, although less remaining cartilage was observed (Figure 2E-2J). Histomorphometric measurements further confirmed the inhibition of bone regeneration in these two transgenic mice (Figures 2K and S1).
###end p 69
###begin p 70
###xml 88 96 88 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">Figure 2</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g002">2</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b033">33</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b034">34</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b035">35</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 583 598 <span type="species:ncbi:10090">transgenic mice</span>
We also observed a significant down-regulation of SOX9 and RUNX2 in both of these mice (Figure 2L and 2M). SOX9 is a transcription factor for chondrogenic differentiation, and is expressed in chondroprogenitors and chondrocytes [33,34]. RUNX2 is a transcription factor up-regulated during osteoblast differentiation, and is also expressed by some hypertrophic chondrocytes [35]. The down-regulation of these two transcription factors, in agreement with our histological findings, suggests a lack of both chondrogenic and osteogenic differentiation at the fracture sites in these two transgenic mice.
###end p 70
###begin title 71
beta-Catenin Is Regulated by WNTs during Fracture Repair
###end title 71
###begin p 72
###xml 339 348 336 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg002">Figure S2</xref>
###xml 439 441 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b036">36</xref>
###xml 442 444 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b037">37</xref>
###xml 707 716 694 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg002">Figure S2</xref>
###xml 749 751 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 801 803 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b038">38</xref>
Since beta-catenin can be regulated by WNT ligands, we examined the expression of WNTs and their receptors in the fracture callus using RT-PCR. Many WNT ligands were expressed during fracture healing, including WNT4, 5b, 10b, 11 and 13. Furthermore, the receptors FZ1, 2, 4, and 5, and LRP6 were also up-regulated during fracture healing (Figure S2). Since WNT4 and WNT10b could mediate canonical WNT signaling (WNT/beta-catenin pathway) [36,37], it is likely that these WNT ligands are responsible for activating beta-catenin signaling during fracture repair. Furthermore, we also observed an up-regulation of WNT5a and protein kinase C alpha (PKCalpha) during fracture repair using Western blot analysis (Figure S2). Since WNT5a can mediate WNT/Ca2+ pathway signaling through its mediator PKCalpha [38], our results imply that the WNT signaling pathway is complex during fracture healing, likely involving activation of both canonical and noncanonical WNT pathways.
###end p 72
###begin p 73
###xml 239 241 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b039">39</xref>
###xml 242 244 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b040">40</xref>
###xml 412 420 406 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
###xml 588 596 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
To investigate the contribution of WNT ligands to beta-catenin regulation in fracture repair, we used an adenovirus expressing a His-tagged DKK1, an antagonist of canonical WNT/beta-catenin signaling that inhibits WNT receptor activation [39,40]. Ad-GFP was also injected into the fracture site as a control. DKK1 expression was detected by Western blot analysis using anti-His antibody 1 wk following fracture (Figure 3A). Callus samples from animals treated with Ad-DKK1 exhibited a substantial reduction of beta-catenin protein level, as compared to those injected with control virus (Figure 3B), confirming that WNT ligands regulate beta-catenin during fracture repair.
###end p 73
###begin title 74
WNT Ligands Regulate beta-Catenin during Fracture Healing
###end title 74
###begin p 75
(A) Western blot analysis shows expression of DKK1 as detected by an antibody to the His tag.
###end p 75
###begin p 76
(B) beta-catenin was substantially down-regulated in fractures treated with DKK1.
###end p 76
###begin p 77
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
(C and D) SO staining of fracture samples from DKK1-treated mice (C) and control mice (D) at 1 wk after fracture show that DKK1 treatment down-regulates chondrogenic differentiation. Images are magnified 25x.
###end p 77
###begin p 78
###xml 172 176 <span type="species:ncbi:10090">mice</span>
(E) Histomorphometric analysis shows a down-regulation of cartilage volume (CV) at 1 wk after fracture, as a percentage of total callus tissue volume (TV), in DKK1-treated mice.
###end p 78
###begin p 79
(F and G) SOX9 was also down-regulated after treatment with Ad-DKK1 at 1 wk following fracture. The expression data are consistent with our histological findings.
###end p 79
###begin p 80
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
(H and I) Radiographic analysis from DKK1-treated mice (H) and from control mice (I), at 3 wk after fracture, shows a lack of healing in the DKK1-treated animals. Arrows indicate fracture site.
###end p 80
###begin p 81
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
(J-M) HE staining from DKK1-treated mice (J and L) and from control mice (K and M) undifferentiated mesenchymal-like cells at the fracture site in DKK1-treated animals at 3 wk after fracture. Images (J and K) are magnified 25x; (L and M) show 100x magnifications of the area shown in the box in the lower-magnification images.
###end p 81
###begin p 82
(N) Assay of bone volume (BV) as a percentage of total callus tissue volume (TV) shows a significant decrease in bone regeneration after DKK1 treatment.
###end p 82
###begin p 83
###xml 70 74 <span type="species:ncbi:10090">mice</span>
(O and P) RUNX2 was also significantly down-regulated in DKK1-treated mice, suggesting an inhibition of osteoblastic differentiation.
###end p 83
###begin p 84
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">3</xref>
###xml 348 356 345 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
###xml 362 363 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">3</xref>
###xml 501 509 498 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
###xml 515 516 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">3</xref>
###xml 714 722 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
###xml 724 725 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">3</xref>
###xml 805 814 802 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figures 3</xref>
###xml 820 822 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg001">S1</xref>
###xml 1240 1248 1231 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">Figure 3</xref>
###xml 1254 1255 1245 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g003">3</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
At 1 wk after the fracture, SO staining and histomorphometric analysis showed that almost no cartilage islands were present in mice treated with DKK1, as compared to control animals (Figure 3C-3E). SOX9 was also down-regulated after treatment of Ad-DKK1, suggesting an inhibition of chondrogenic differentiation after blocking of WNT/beta-catenin (Figure 3F and 3G). At 3 wk after the fracture, all of the control animals showed complete healing, while in DKK1-treated mice, fractures failed to heal (Figure 3H and 3I). There was a substantial reduction of both bone and cartilage volume in DKK1-treated mice, and the fracture site was mainly filled with large amount of undifferentiated mesenchymal-like tissues (Figure 3J-3M). Histomorphometric measurements confirmed this inhibition of bone formation (Figures 3N and S1). These phenotypes were nearly identical to the results in mice expressing Cre-mediated conditional beta-catenin null alleles, suggesting a substantial inhibition of bone healing by inactivation of the WNT/beta-catenin pathway. Furthermore, we examined the expression of RUNX2 in these mice, and observed that RUNX2 was expressed at substantially lower levels in mice expressing DKK1, as compared to control animals (Figure 3O and 3P).
###end p 84
###begin title 85
beta-Catenin Plays a Disparate Role in Undifferentiated Mesenchymal Cells and Cells Committed to the Osteoblast Lineage
###end title 85
###begin p 86
###xml 269 282 263 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Cre</italic>
###xml 304 307 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 335 337 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b027">27</xref>
###xml 430 434 413 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 415 434 402 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 502 506 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 487 506 467 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 573 577 545 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 558 577 534 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 615 617 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b016">16</xref>
###xml 716 724 685 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">Mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
To determine the function of beta-catenin in osteoblasts, we observed fracture healing in mice in which beta-catenin loss-of-function or gain-of-function was restricted to cells committed to the osteoblast lineage. Mice expressing conditional alleles were crossed with alpha1(I)-Cre mice (which restrict Cre expression to osteoblasts [27]), resulting in mice expressing the beta-catenin null allele in osteoblasts [alpha1(I)-Catnbnull] or beta-catenin stabilized alleles in osteoblasts [alpha1(I)-Catnbstab]. A significant increase in bone mass was found in alpha1(I)-Catnbstab mutant mice, as previously reported [16]. Western blot analysis confirmed the expected changes in beta-catenin protein level in the mice (Figure 4A)
###end p 86
###begin title 87
###xml 48 52 <span type="species:ncbi:10090">Mice</span>
beta-Catenin Acts to Regulate Bone Formation in Mice Expressing Osteoblast-Specific beta-Catenin Null or Stabilized Alleles
###end title 87
###begin p 88
###xml 106 110 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 91 110 88 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 130 134 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 115 134 108 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 136 150 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-null</italic>
###xml 155 170 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-stab,</italic>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
(A) Western blot analysis shows that beta-catenin was regulated in the bone as expected in alpha1(I)-Catnbnull and alpha1(I)-Catnbstab (alpha1(I)-null and alpha1(I)-stab, respectively) mice.
###end p 88
###begin p 89
(B) Histomorphometric analysis of calluses at 1 wk following fracture, as indicated by cartilage volume (CV) as a percentage of total callus tissue volume (TV).
###end p 89
###begin p 90
###xml 48 52 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 33 52 33 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 83 87 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 68 87 64 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
(C-E) Radiographic analysis from alpha1(I)-Catnbnull mice (C), from alpha1(I)-Catnbstab mice (D), and from wild-type littermate mice (E) at 3 wk after fracture. Arrows indicate fracture site.
###end p 90
###begin p 91
###xml 38 42 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 23 42 23 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 79 83 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 64 83 60 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 190 194 178 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 175 194 167 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 286 290 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 271 290 259 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
(F-K) HE staining from alpha1(I)-Catnbnull mice (F and I), from alpha1(I)-Catnbstab mice (G and J), and from wild-type mice (H and K) shows that bone healing was inhibited in alpha1(I)-Catnbnull mice at 3 wk after fracture, with remaining cartilage at the fracture site. alpha1(I)-Catnbstab mice showed an accelerated fracture repair with abundant new bone tissue formed. Images (F, G, and H) are 25x magnifications; (I, J, and K) are 100x magnifications of the areas shown in the box in the lower-magnification images.
###end p 91
###begin p 92
###xml 105 109 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 90 109 90 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 160 164 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 145 164 141 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
(L) Relative radiopaque bone density at the fracture site shows decreased bone density in alpha1(I)-Catnbnull mice and increased bone density in alpha1(I)-Catnbstab mice.
###end p 92
###begin p 93
###xml 107 111 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 92 111 92 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 229 233 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 214 233 207 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
(M) Assay of bone volume (BV) as a percentage of total callus tissue volume (TV) shows that alpha1(I)-Catnbnull mice displayed inhibition of fracture healing, whereas osteoblast-specific beta-catenin activation in alpha1(I)-Catnbstab mice enhanced bone healing.
###end p 93
###begin p 94
###xml 92 96 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 113 117 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 77 118 77 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup>, &#945;1(I)-Catnb<sup>stab</sup>,</italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
(N and O) Regulation of SOX9 at 1 wk and RUNX2 at 3 wk following fracture in alpha1(I)-Catnbnull, alpha1(I)-Catnbstab, and wild-type mice.
###end p 94
###begin p 95
###xml 47 51 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 32 51 32 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 177 181 169 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 162 181 158 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 266 274 258 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 349 353 337 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 334 353 326 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 520 528 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 534 535 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 612 616 596 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 597 616 585 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 654 662 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 772 776 752 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 757 776 741 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 783 791 763 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 797 798 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 908 912 884 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 893 912 873 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 926 935 902 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figures 4</xref>
###xml 941 943 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg001">S1</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
At 1 wk following the fracture, alpha1(I)-Catnbnull mice exhibited a fracture callus mainly composed of cartilage matrix, while chondrogenesis was not evident in alpha1(I)-Catnbstab mice (unpublished data). Histomorphometric assay confirmed these histology changes (Figure 4B). At 3 wk after the fracture, radiographic examination in alpha1(I)-Catnbnull mice showed that, although there was some calcified callus present, the newly formed bone had not completely bridged the fracture gap, as compared to wild-type mice (Figure 4C and 4E). Radiographic quantification confirmed low bone density in alpha1(I)-Catnbnull mice, as compared to wild-type mice (Figure 4L). Histological examination showed that the bone ends were not completely approximated in the alpha1(I)-Catnbnull mice (Figure 4F and 4I). Histomorphometric analysis further showed a significant repression of bone regeneration in alpha1(I)-Catnbnull mutant mice (Figures 4M and S1).
###end p 95
###begin p 96
###xml 57 61 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 42 61 42 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 203 211 199 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 217 218 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 371 375 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 356 375 352 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 465 474 457 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figures 4</xref>
###xml 477 478 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 481 482 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 485 486 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 488 489 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 496 498 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg001">S1</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Surprisingly, radiographic examination in alpha1(I)-Catnbstab mice showed enhanced fracture healing, characterized by a calcified callus bridging the fracture gap as well as an increase in bone density (Figure 4D and 4E). Radiographic quantification, histological studies, and histomorphometric analysis further revealed that, compared to control animals, alpha1(I)-Catnbstab mutant mice showed a larger volume of regenerated bone tissues within the fracture site (Figures 4G, 4H, 4J, 4K-4M, and S1).
###end p 96
###begin p 97
###xml 145 149 141 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 130 149 130 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 214 218 206 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 199 218 195 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 321 329 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">Figure 4</xref>
###xml 335 336 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g004">4</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
We also examined expression of SOX9 at 1 wk following fracture, and observed an up-regulation of this transcription factor in the alpha1(I)-Catnbnull mutant mice. However, SOX9 was down-regulated in alpha1(I)-Catnbstab mutant animals. Expression of RUNX2 in these two mice, however, was regulated in the opposite manner (Figure 4N and 4O).
###end p 97
###begin p 98
###xml 212 214 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b027">27</xref>
Since these conditional beta-catenin alleles are regulated by a collagen type I promoter and thus are present in precursor cells committed to the osteoblast lineage but not in undifferentiated mesenchymal cells [27], our results support the concept that early osteoblast lineage cells lacking beta-catenin are blocked in osteoblast differentiation and develop a chondrocyte phenotype instead. Expression of stabilized beta-catenin in cells committed to the osteoblast lineage improves osteogenesis, thus leading to enhanced fracture healing.
###end p 98
###begin title 99
Lithium Treatment Enhances Healing if Started after the Fracture
###end title 99
###begin p 100
###xml 65 67 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b041">41</xref>
###xml 68 70 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b043">43</xref>
###xml 143 145 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b031">31</xref>
###xml 409 417 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">Figure 5</xref>
###xml 672 680 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">Figure 5</xref>
###xml 682 683 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">5</xref>
###xml 735 743 726 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">Figure 5</xref>
###xml 749 750 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">5</xref>
###xml 1084 1092 1075 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">Figure 5</xref>
###xml 1098 1099 1089 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040249-g005">5</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">Mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
Lithium activates beta-catenin signaling by inhibiting GSK3beta [41-43]. Also, lithium enhances bone formation and improves bone mass in mice [31]. To asses the effect of lithium on fracture repair, treatment was started either 2 wk prior to initiating the fracture, or 4 d following the fracture in wild-type mice. Lithium treatment increased the level of beta-catenin in the fracture tissue in both groups (Figure 5A). Mice in which the lithium treatment was started before the fracture had reduced bone in the fracture site, while mice in which the lithium treatment was started late displayed an enhanced fracture healing with relatively high radiopaque bone density (Figure 5B-5D). Histological examination of the fracture sites (Figure 5E and 5F) shows undifferentiated mesenchymal cells at the fracture site with early lithium treatment, while there is increased bone volume at the fracture site with late treatment. Radiographic and histomorphometric analysis further provided evidence that LiCl treatment enhances fracture healing, but only when utilized after the fracture (Figure 5G and 5H).
###end p 100
###begin title 101
Lithium Treatment Regulates Bone Mass at the Fracture Site
###end title 101
###begin p 102
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were treated with lithium starting either 2 wk before the fracture (early treatment) or 4 d after the fracture (late treatment).
###end p 102
###begin p 103
###xml 50 54 <span type="species:ncbi:10090">mice</span>
(A) beta-catenin increased 3 wk after fracture in mice receiving either early or late lithium treatment.
###end p 103
###begin p 104
###xml 33 37 <span type="species:ncbi:10090">mice</span>
(B-D) Radiographic analysis from mice receiving early lithium treatment (B), late lithium treatment (C), or NaCl as a control (D), show that lithium enhanced fracture healing only when given late. Arrows indicate the fracture site.
###end p 104
###begin p 105
###xml 27 31 <span type="species:ncbi:10090">mice</span>
(E and F) HE staining from mice receiving early or late lithium treatments, respectively (25x). There is immature mesenchymal tissue at the fracture site in (E), and large amounts of bone in (F).
###end p 105
###begin p 106
(G) Relative radiopaque bone density results show that early and late treatment have opposite effects on fracture healing.
###end p 106
###begin p 107
(H) Histomorphometric analysis on bone volume (BV) as a percentage of total callus tissue volume (TV), showing that pharmacologic activation of beta-catenin after healing cells become committed to the osteoblast lineage could improve healing, while treatment at earlier time points inhibited fracture repair.
###end p 107
###begin p 108
###xml 173 179 167 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 168 179 162 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 370 376 364 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 365 376 359 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 419 428 413 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040249-sg003">Figure S3</xref>
###xml 537 541 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 522 541 513 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 867 871 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 852 871 836 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
Lithium can have other cellular effects in addition to inhibiting GSK3beta. To determine if lithium is indeed acting through beta-catenin, we gave lithium treatment to Catnbtm2Kem mice in which the conditional null allele was activated by Ad-Cre. We found that mice expressing the null allele did not form as much bone at the fracture site as did wild-type mice or Catnbtm2Kem mice treated with lithium but not Ad-Cre (Figure S3), suggesting that lithium acts at least in part through beta-catenin. Although data from the alpha1(I)-Catnbstab mice may be confounded by an increased bone density prior to the fracture, the results from lithium treatment shows that stabilization of beta-catenin through a pharmacologic approach initiated after the fracture results in a similar enhancement in bone healing. This suggests that the enhanced bone repair in alpha1(I)-Catnbstab mice is due to beta-catenin levels in the fracture healing cells committed to the osteoblast phenotype in the healing fracture, rather than to the underlying increased bone mass alone.
###end p 108
###begin p 109
Taken together, our results confirm that lithium increases bone healing through its activation of beta-catenin signaling pathway. These data, therefore, not only support our notion that beta-catenin signaling functions differently at different stages of fracture repair, but more importantly, raises the possibility that lithium treatment can be used to enhance bone repair.
###end p 109
###begin title 110
Discussion
###end title 110
###begin p 111
In this study, we demonstrated that beta-catenin signaling plays a crucial role in fracture healing. We observed that precise regulation of beta-catenin is important in the early phases of fracture healing to allow differentiation of mesenchymal cells into osteoblast and chondrocyte lineages. Our findings also indicate that beta-catenin plays a disparate role in undifferentiated mesenchymal cells and in committed osteoblasts, and as such acts differently during different phases of fracture repair. These findings are important not only for understanding the role of beta-catenin in different cell types, but also has a practical implication for therapy-pre-fracture lithium treatment inhibits the repair process, but post-fracture treatment enhanced bone healing. As such, lithium will enhance fracture healing, but only if started after cells have become committed to the osteoblast lineage.
###end p 111
###begin p 112
###xml 807 809 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b044">44</xref>
###xml 1042 1044 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b045">45</xref>
During fracture repair, beta-catenin-mediated TCF-dependent transcription is not activated in the earliest mesenchymal tissues present at the fracture site. Once cells that begin to show phenotypic features of either chondrocyte or osteoblast precursors, they exhibit beta-catenin-mediated TCF-dependent transcription activity, suggesting a role in the initial phases of differentiation. In osteoblast lineage cells, beta-catenin signaling activity decreased in later phases of differentiation, as osteoblasts matured into osteocytes. This finding is in agreement with a previous in vitro study, in which van der Horst and colleagues also observed a down-regulation of beta-catenin signaling during the formation of a mineralized bone matrix in KS483 cells undergoing late phase osteoblast differentiation [44], suggesting a similar role for beta-catenin in osteoblasts in fracture healing. During limb development, beta-catenin is expressed in prechondrogenic mesenchymal cells but is significantly decreased in differentiated chondrocytes [45]. However, in our study, we found that beta-catenin-mediated TCF-dependent transcription was also activated in chondrocytes and, to a lesser extent, in prehypertrophic chondrocytes. Thus, the range of activity for beta-catenin mediated TCF-dependent transcription in chondrocytes is greater in fracture healing than in development, suggesting that beta-catenin plays a role in chondrocytes over a broader range of differentiation in repair than in development.
###end p 112
###begin p 113
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b036">36</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b037">37</xref>
###xml 755 757 746 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 785 787 776 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 799 801 790 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 924 926 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b038">38</xref>
###xml 927 929 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b046">46</xref>
###xml 993 995 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b047">47</xref>
###xml 996 998 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b048">48</xref>
Our results showed that many WNT ligands and receptors are selectively up-regulated during bone healing, several of which (e.g., WNT4, WNT10b, and LRP6) are known to activate the canonical WNT pathway [36,37]. Moreover, our data showing that DKK1 treatment inhibits beta-catenin signaling and suppresses fracture repair suggest that the canonical WNT pathway is the dominant mechanism regulating beta-catenin during bone healing. Since multiple WNT ligands that activate beta-catenin signaling are expressed during the repair process, there is likely functional redundancy. However, our results do not exclude the possibility that noncanonical WNT pathways are also likely activated during fracture repair, as WNT5a and WNT11 can signal through the WNT/Ca2+ pathway, which regulates Ca2+ flux and Ca2+-sensitive protein kinases and transcription factors, such as PKCalpha and calcium/calmodulin-dependent protein kinase II [38,46]. WNT11 can also activate the c-Jun N-terminal kinase pathway [47,48]. Indeed, in our study, we not only noticed that WNT11 was expressed during fracture healing, but also observed an activation of both WNT5a and its mediator PKCalpha. These results suggest that the role for WNT ligands in fracture repair is complex, potentially involving activation of multiple pathways (i.e., canonical and noncanonical WNT pathways).
###end p 113
###begin p 114
###xml 647 649 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b049">49</xref>
###xml 650 652 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b050">50</xref>
###xml 702 710 693 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 697 710 688 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>lox(ex3)</sup></italic>
###xml 997 1001 981 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 982 1001 970 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>stab</sup></italic>
###xml 1722 1724 1697 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b049">49</xref>
###xml 1725 1727 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b051">51</xref>
###xml 144 148 <span type="species:ncbi:10090">Mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
We observed that beta-catenin-mediated TCF-dependent transcription is activated during both chondrogenesis and osteogenesis in fracture repair. Mice expressing conditional beta-catenin null alleles after treatment of Cre recombinase failed to heal, and there was a lack of bone and cartilage at the fracture site. The histology studies showed immature mesenchymal cells at the fracture sites. This finding is not unexpected given the role of beta-catenin during fetal bone development, in which conditional deficiency in early osteoblast progenitors results in a blockade of osteoblast differentiation, with immature mesenchymal cells persisting [49,50]. However, fractures also failed to heal in Catnblox(ex3) mice whose beta-catenin-encoding gene had been stabilized by treatment with Cre recombinase. The fracture site in this case was also composed of immature mesenchymal cells, suggesting a block to differentiation. This observation was in stark contrast to the results from alpha1(I)-Catnbstab mice, which expressed osteoblast-specific stabilized beta-catenin alleles; these mice exhibited significantly enhanced bone healing. Thus, during fracture healing, Cre-mediated conditional beta-catenin stabilization represses differentiation of these mesenchymal cells, perhaps maintaining these cells in an undifferentiated proliferative state. Previous in vitro studies and studies of bone development provide evidence to support this notion, as WNT signaling activation maintains mesenchymal stem cells in a less differentiated state during osteogenic differentiation, and stabilization of beta-catenin can interfere with the differentiation of precursors into chondrocytes as well as osteoblasts during development [49-51]. In cells that have already adopted an osteoblast phenotype, beta-catenin signaling activation works differently; that is, it promotes osteoblastic differentiation and enhances osteogenesis. Therefore, the level of beta-catenin needs to be precisely regulated at the earliest phase of fracture healing to allow for proper differentiation.
###end p 114
###begin p 115
###xml 43 47 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 28 47 28 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup></italic>
###xml 124 130 120 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 119 130 115 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup></italic>
###xml 648 650 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b049">49</xref>
###xml 651 653 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b050">50</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Interestingly, fractures in alpha1(I)-Catnbnull mice healed with abundant cartilage matrix at the fracture site, while Catnbtm2Kem mice in which conditional beta-catenin null alleles were regulated by Ad-Cre mainly exhibited undifferentiated mesenchymal-like cells at the fracture site. These data imply that mesenchymal precursors that have already become committed to an osteoblast phenotype will adopt a chondroblastic phenotype instead if beta-catenin is absent. This result agrees with data from bone development, which show that osteoblast precursors lacking beta-catenin are blocked in differentiation and develop into chondrocytes instead [49,50].
###end p 115
###begin p 116
###xml 474 476 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b041">41</xref>
###xml 477 479 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b043">43</xref>
###xml 574 576 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b031">31</xref>
###xml 928 930 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040249-b052">52</xref>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 850 856 <span type="species:ncbi:9606">humans</span>
Our findings raise the possibility that therapy to activate beta-catenin could be used to enhance fracture repair. However, since activation of beta-catenin signaling inhibits differentiation of mesenchymal cells not yet committed to the osteoblastic phenotype, such treatment should be utilized only after cells are committed to the osteoblast lineage. One potential therapeutic agent is lithium, which activates the canonical WNT signaling through inhibition of GSK3beta [41-43], and has demonstrated its capacity to increase bone formation and improve bone mass in mice [31]. We found that lithium treatment greatly up-regulates beta-catenin, and indeed has the potential to enhance fracture healing, but only if started several days after the fracture has occurred. Since lithium is a pharmacologic agent, and oral lithium has been used to treat humans with bipolar disease for over a half-century with substantial benefit [52], its use to improve bone repair could readily be tested in the clinical setting.
###end p 116
###begin title 117
Supporting Information
###end title 117
###begin title 118
Translation of the Abstract into Mandarin by Yan Chen
###end title 118
###begin p 119
(144 KB PDF)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin title 121
Detailed Histomorphometric Data
###end title 121
###begin p 122
###xml 559 561 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
###xml 567 568 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 620 621 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For histomorphometric analysis, callus tissues at 3 wk after fracture were fixed in 4% paraformaldehyde, decalcified in 20% EDTA (pH 7.4), and embedded in paraffin. 10 mum sections were prepared and stained with HE. For each callus, an average of ten tissue sections was used to determine callus parameters, including trabecular thickness (mum), trabecular number (per mm), and trabecular separation (mum). Four animals were analyzed for each group. Data were expressed as mean +/- standard deviation. Statistical differences were calculated by using Student t-test. p < 0.001 was considered statistically significant (*p < 0.001).
###end p 122
###begin p 123
###xml 53 59 53 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 66 74 66 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 48 75 48 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup>, Catnb<sup>lox(ex3)</sup>,</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
(A) Trabecular number assay from Ad-Cre-treated Catnbtm2Kem, Catnblox(ex3), and Ad-GFP-treated control mice.
###end p 123
###begin p 124
###xml 56 62 56 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 69 77 69 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 51 78 51 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup>, Catnb<sup>lox(ex3)</sup>,</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
(B) Trabecular thickness assay from Ad-Cre-treated Catnbtm2Kem, Catnblox(ex3), and Ad-GFP-treated control mice.
###end p 124
###begin p 125
###xml 57 63 57 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Kem</sup>
###xml 70 78 70 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox(ex3)</sup>
###xml 52 79 52 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Catnb<sup>tm2Kem</sup>, Catnb<sup>lox(ex3)</sup>,</italic>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
(C) Trabecular separation assay from Ad-Cre-treated Catnbtm2Kem, Catnblox(ex3), and Ad-GFP-treated control mice.
###end p 125
###begin p 126
###xml 71 75 <span type="species:ncbi:10090">mice</span>
(D) Trabecular number assay from Ad-DKK1- and Ad-GFP-treated wild-type mice.
###end p 126
###begin p 127
###xml 74 78 <span type="species:ncbi:10090">mice</span>
(E) Trabecular thickness assay from Ad-DKK1- and Ad-GFP-treated wild-type mice.
###end p 127
###begin p 128
###xml 75 79 <span type="species:ncbi:10090">mice</span>
(F) Trabecular separation assay from Ad-DKK1- and Ad-GFP-treated wild-type mice.
###end p 128
###begin p 129
###xml 48 52 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 69 73 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 33 74 33 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup>, &#945;1(I)-Catnb<sup>stab</sup>,</italic>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
(G) Trabecular number assay from alpha1(I)-Catnbnull, alpha1(I)-Catnbstab, and wild-type mice.
###end p 129
###begin p 130
###xml 51 55 47 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 72 76 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 36 77 36 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup>, &#945;1(I)-Catnb<sup>stab</sup>,</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
(H) Trabecular thickness assay from alpha1(I)-Catnbnull, alpha1(I)-Catnbstab, and wild-type mice.
###end p 130
###begin p 131
###xml 52 56 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</sup>
###xml 73 77 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stab</sup>
###xml 37 78 37 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I)-Catnb<sup>null</sup>, &#945;1(I)-Catnb<sup>stab</sup>,</italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
(I) Trabecular separation assay from alpha1(I)-Catnbnull, alpha1(I)-Catnbstab, and wild-type mice.
###end p 131
###begin p 132
(781 KB PDF)
###end p 132
###begin p 133
Click here for additional data file.
###end p 133
###begin title 134
WNT-Related Gene Expression
###end title 134
###begin p 135
At different time points after fracture, calluses were harvested and total RNA was isolated. Expression of mRNA was compared to that of the housekeeping control beta-2 macroglobin. All experiments were performed in triplicate. Protein extracts were also isolated, and Western blot analysis was performed to determine protein expression. Protein expression was also normalized to GAPDH as a loading control.
###end p 135
###begin p 136
(A) Several WNT ligands (WNT4, 5b, 10b, 11, and 13) and receptors (FZ1, 2, 4, and 5, and LRP6) were activated at mRNA level during fracture healing.
###end p 136
###begin p 137
(B) Both WNT5a and its signaling mediator PKCalpha were up-regulated during fracture repair.
###end p 137
###begin p 138
(737 KB PDF)
###end p 138
###begin p 139
Click here for additional data file.
###end p 139
###begin title 140
The Effect of Lithium Treatment on Bone Density is Partially Mediated by beta-Catenin
###end title 140
###begin p 141
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
Bone healing was observed 3 wk following generation of a tibia fracture in mice treated with lithium or control started after creation of the fracture. There were five mice in each group. In mice expressing beta-catenin null alleles activated by treatment with Ad-Cre there was reduced bone mass compared to mice in which Ad-Cre was not administered or mice in which neither Ad-Cre nor lithium was administered. An asterisk above the mean indicates a statistically significant difference between beta-catenin null and wild-type mice treated with lithium. Control mice (not treated with lithium) were assigned an average relative bone density of 1. These data show that the effect of lithium is at least partially mediated by beta-catenin.
###end p 141
###begin p 142
(2.6 MB PDF)
###end p 142
###begin p 143
Click here for additional data file.
###end p 143
###begin title 144
PCR Primer Sequences
###end title 144
###begin p 145
(781 KB PDF)
###end p 145
###begin p 146
Click here for additional data file.
###end p 146
###begin title 147
Antibodies Used in This Study
###end title 147
###begin p 148
(781 KB PDF)
###end p 148
###begin p 149
Click here for additional data file.
###end p 149
###begin p 150
We thank Calvin J. Kuo at Stanford University School of Medicine for providing us with adenovirus vector expressing DKK1. BAA is supported by the Canadian Research Chair's Program and YC is supported by the Premier's Research Excellence Program of Ontario.
###end p 150
###begin title 151
Abbreviations
###end title 151
###begin p 152
dickkopf
###end p 152
###begin p 153
dishevelled
###end p 153
###begin p 154
frizzled
###end p 154
###begin p 155
glyceraldehyde 3-phosphate dehydrogenase
###end p 155
###begin p 156
glycogen synthase kinase 3 beta
###end p 156
###begin p 157
hematoxylin-eosin
###end p 157
###begin p 158
lymphoid enhancer factor
###end p 158
###begin p 159
low-density lipoprotein jureceptor-related protein
###end p 159
###begin p 160
protein kinase C alpha
###end p 160
###begin p 161
small interfering RNA
###end p 161
###begin p 162
safranin O
###end p 162
###begin p 163
T cell factor
###end p 163
###begin p 164
WNT1-induced secreted protein 1
###end p 164
###begin title 165
References
###end title 165
###begin article-title 166
Bone development and repair
###end article-title 166
###begin article-title 167
Current concepts of molecular aspects of bone healing
###end article-title 167
###begin article-title 168
The cell and molecular biology of fracture healing
###end article-title 168
###begin article-title 169
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy
###end article-title 169
###begin article-title 170
Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair
###end article-title 170
###begin article-title 171
Development and regeneration of the musculoskeletal system
###end article-title 171
###begin article-title 172
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis
###end article-title 172
###begin article-title 173
Wnt/beta-catenin signaling
###end article-title 173
###begin article-title 174
Genetic disorders of the LRP5-Wnt signaling pathway affecting the skeleton
###end article-title 174
###begin article-title 175
Cross-regulation of the Wnt signaling pathway: A role of MAP kinases
###end article-title 175
###begin article-title 176
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-beta3 and beta-catenin and promotes GSK-beta3-dependent phosphorylation of beta-catenin
###end article-title 176
###begin article-title 177
Regulation of LEF-1/TCF transcription factors by Wnt and other signals
###end article-title 177
###begin article-title 178
The ins and outs of Wingless signaling
###end article-title 178
###begin article-title 179
Sequential roles of Hedgehog and Wnt signaling in osteoblast development
###end article-title 179
###begin article-title 180
Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
###end article-title 180
###begin article-title 181
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
###end article-title 181
###begin article-title 182
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
###end article-title 182
###begin article-title 183
High bone density due to a mutation in LDL-receptor-related protein 5
###end article-title 183
###begin article-title 184
Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair
###end article-title 184
###begin article-title 185
Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation
###end article-title 185
###begin article-title 186
WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair
###end article-title 186
###begin article-title 187
Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
###end article-title 187
###begin article-title 188
Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing
###end article-title 188
###begin article-title 189
Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1
###end article-title 189
###begin article-title 190
Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development
###end article-title 190
###begin article-title 191
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene
###end article-title 191
###begin article-title 192
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast
###end article-title 192
###begin article-title 193
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
A standardized experimental fracture in the mouse tibia
###end article-title 193
###begin article-title 194
Molecular aspects of healing in stabilized and non-stabilized fractures
###end article-title 194
###begin article-title 195
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Lithium inhibits the development of physical dependence to clonidine in mice
###end article-title 195
###begin article-title 196
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice
###end article-title 196
###begin article-title 197
Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing
###end article-title 197
###begin article-title 198
Sox-9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1 (II) collagen gene
###end article-title 198
###begin article-title 199
Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer
###end article-title 199
###begin article-title 200
Cbfa1: A molecular switch in osteoblast biology
###end article-title 200
###begin article-title 201
###xml 57 64 <span type="species:ncbi:9031">chicken</span>
Dual roles of Wnt signaling during chondrogenesis in the chicken limb
###end article-title 201
###begin article-title 202
Wnt-5a and Wnt-5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation
###end article-title 202
###begin article-title 203
Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner
###end article-title 203
###begin article-title 204
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
###end article-title 204
###begin article-title 205
Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow
###end article-title 205
###begin article-title 206
Molecular targets of lithium action
###end article-title 206
###begin article-title 207
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3
###end article-title 207
###begin article-title 208
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
###end article-title 208
###begin article-title 209
Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells
###end article-title 209
###begin article-title 210
Regulation of the chondrocyte phenotype by beta-catenin
###end article-title 210
###begin article-title 211
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements
###end article-title 211
###begin article-title 212
###xml 65 74 <span type="species:ncbi:7955">zebrafish</span>
Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation
###end article-title 212
###begin article-title 213
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 86 93 <span type="species:ncbi:8355">Xenopus</span>
Antagonistic interaction between IGF and Wnt/JNK signaling in convergent extension in Xenopus embryo
###end article-title 213
###begin article-title 214
Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors
###end article-title 214
###begin article-title 215
Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes
###end article-title 215
###begin article-title 216
###xml 81 86 <span type="species:ncbi:9606">human</span>
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells
###end article-title 216
###begin article-title 217
Lithium treatment at 52
###end article-title 217
###begin p 218
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 326 341 <span type="species:ncbi:10090">transgenic mice</span>
Author contributions. YC and BAA designed the study. YC, PN, QW, RP, and BAA analyzed the data. BAA enrolled patients. YC and BAA contributed to writing the paper. YC, HCW, and ACL collected data or performed experiments for this study. ACL provided mice expressing osteoblast-specific beta-catenin null alleles. PN helped in transgenic mice work. QW provided the Ad-Cre virus that was used for this study.
###end p 218
###begin p 219
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This work was supported by grants from the Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 219
###begin p 220
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 220

